Computational Redesign of the SHV-1 β-Lactamase/β-Lactamase Inhibitor Protein Interface

被引:39
|
作者
Reynolds, Kimberly A. [1 ,2 ]
Hanes, Melinda S. [1 ,2 ]
Thomson, Jodi M. [3 ,4 ]
Antczak, Andrew J. [5 ]
Berger, James M. [5 ]
Bonomo, Robert A. [3 ,4 ]
Kirsch, Jack F. [5 ]
Handel, Tracy M. [1 ]
机构
[1] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[2] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA
[3] Case Western Reserve Univ, Sch Med, Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[5] Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
SHV-1; beta-lactamase; beta-lactamase inhibitor protein (BLIP); computational protein design; EGAD; protein-protein interactions;
D O I
10.1016/j.jmb.2008.05.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-lactamases are enzymes that catalyze the hydrolysis of beta-lactam antibiotics. beta-lactamase/beta-lactamase inhibitor protein (BLIP) complexes are emerging as a well characterized experimental model system for studying protein-protein interactions. BLIP is a 165 amino acid protein that inhibits several class A beta-lactamases with a wide range of affinities: picomolar affinity for K1; nanomolar affinity for TEM-1, SME-1, and BlaI; but only micromolar affinity for SHV-1 beta-lactamase. The large differences in affinity coupled with the availability of extensive mutagenesis data and high-resolution crystal structures for the TEM-1/BLIP and SHV-1/BLIP complexes make them attractive systems for the further development of computational design methodology. We used EGAD, a physics-based computational design program, to redesign BLIP in an attempt to increase affinity for SHV-1. Characterization of several of designs and point mutants revealed that in all cases, the mutations stabilize the interface by 10- to 1000-fold relative to wild type BLIP. The calculated changes in binding affinity for the mutants were within a mean absolute error of 0.87 kcal/mol from the experimental values, and comparison of the calculated and experimental values for a set of 30 SHV-1/BLIP complexes yielded a correlation coefficient of 0.77. Structures of the two complexes with the highest affinity, SHV-1/BLIP (E73M) and SHV-1/BLIP (E73M, S130K, S146M), are presented at 1.7 angstrom resolution. While the predicted structures have much in common with the experimentally determined structures, they do not coincide perfectly; in particular a salt bridge between SHV-1 D104 and BLIP K74 is observed in the experimental structures, but not in the predicted design conformations. This discrepancy highlights the difficulty of modeling salt bridge interactions with a protein design algorithm that approximates side chains as discrete rotamers. Nevertheless, while local structural features of the interface were sometimes miscalculated, EGAD is globally successful in designing complexes with increased affinity. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:1265 / 1275
页数:11
相关论文
共 50 条
  • [21] SPREAD OF SHV-1 BETA-LACTAMASE IN ESCHERICHIA-COLI ISOLATED FROM FECAL SAMPLES IN AFRICA
    SHAOKAT, S
    OUELLETTE, M
    SIROT, D
    JOLY, B
    CLUZEL, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) : 943 - 945
  • [22] Mass spectrometry analysis of the inhibition of wild type and mutant SHV-1 beta-lactamase with tazobactam.
    Ng, LM
    Pagan-Rodriguez, D
    Simmons, RM
    Zhou, X
    Bonomo, RA
    Hujer, AM
    Anderson, VB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U109 - U109
  • [23] SINGLE AMINO-ACID SUBSTITUTION BETWEEN SHV-1 BETA-LACTAMASE AND CEFOTAXIME-HYDROLYZING SHV-2 ENZYME
    BARTHELEMY, M
    PEDUZZI, J
    BENYAGHLANE, H
    LABIA, R
    FEBS LETTERS, 1988, 231 (01): : 217 - 220
  • [24] Structures of SHV-1 β-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl Conjugation
    Ke, Wei
    Pattanaik, Priyaranjan
    Bethel, Christopher R.
    Sheri, Anjaneyulu
    Buynak, John D.
    Bonomo, Robert A.
    van den Akker, Focco
    PLOS ONE, 2012, 7 (11):
  • [25] Ab Initio Raman Spectra of β-Lactamase Inhibitor Intermediates Bound to E166A SHV β-Lactamase
    Miani, Andrea
    Helfand, Marion Skalweit
    Raugei, Simone
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2009, 5 (08) : 2158 - 2172
  • [26] CLONING OF SHV-2, OHIO-1, AND OXA-6 BETA-LACTAMASES AND CLONING AND SEQUENCING OF SHV-1 BETA-LACTAMASE
    MERCIER, J
    LEVESQUE, RC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) : 1577 - 1583
  • [27] N-TERMINAL AMINO-ACID-SEQUENCE OF PIT-2 BETA-LACTAMASE (SHV-1)
    BARTHELEMY, M
    PEDUZZI, J
    LABIA, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (06) : 839 - 841
  • [28] An ESI-MS/LC-MS analysis of the inhibition of SHV-1 beta-lactamase with tazobactam.
    Ng, LM
    Pagan-Rodriguez, D
    Zhou, X
    Simmons, R
    Bonomo, RA
    Hujer, AM
    Anderson, VB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U128 - U128
  • [29] Detecting a Quasi-stable lmine Species on the Reaction Pathway of SHV-1 β-Lactamase and 6β-(Hydroxymethyl)penicillanic Acid Sulfone
    Che, Tao
    Rodkey, Elizabeth A.
    Bethel, Christopher R.
    Shanmugam, Sivaprakash
    Ding, Zhe
    Pusztai-Carey, Marianne
    Nottingham, Michael
    Chai, Weirui
    Buynak, John D.
    Bonomo, Robert A.
    van den Akker, Focco
    Carey, Paul R.
    BIOCHEMISTRY, 2015, 54 (03) : 734 - 743
  • [30] Rational design of a β-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate:: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone
    Padayatti, Pius S.
    Sheri, Anjaneyulu
    Totir, Monica A.
    Helfand, Marion S.
    Carey, Marianne P.
    Anderson, Vernon E.
    Carey, Paul R.
    Bethel, Christopher R.
    Bonomo, Robert A.
    Buynak, John D.
    van den Akker, Focco
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (40) : 13235 - 13242